Overview

Prostate cancer is the second most common cancer, after skin cancer, among men. It is the second leading cause of cancer death in the United States. This year, it is estimated that about 174,650 men in the United States will be diagnosed with prostate cancer and 31,620 men will die from this disease. Androgen deprivation therapy (ADT) aimed at lowering the level of androgens, is the standard of care for men with advanced prostate cancer. Newly diagnosed metastatic disease that has spread to other parts of the body and still responds to testosterone suppression therapy is called metastatic castration-sensitive prostate cancer (mCSPC). Androgen receptor inhibitors are currently being investigated in combination with ADT given the knowledge that deeper androgen signal inhibition results in further improved outcomes in mCSPC. With the recent drug approvals and updates to clinical practice guidelines, several knowledge, competence and performance gaps exist in the optimal management of mCSPC among oncology practitioners.

This education activity provides guidance on the optimal management of mCSPC and addresses strategies for translating clinical updates into new patient care strategies.

This activity was hosted by the Texas Society of Clinical Oncology (TxSCO)—a Chapter Member of the Association of Community Cancer Centers. 

Speakers

Pedro C. Barata, MD, MSc

Assistant Professor of Medicine Hematology & Medical Oncology, Tulane University

Dr. Pedro Barata earned his medical degree from the New University of Lisbon in 2009 and completed his medical oncology training in 2016. Subsequently, he was invited to join the genitourinary group at Taussig Cancer Center, where he worked as a clinical fellow in genitourinary malignancies. Dr. Barata then moved to Tulane University to continue his clinical and research work in the GU field. Dr. Barata successfully expanded the genitourinary program offered at Tulane Cancer Center and he currently leads the kidney and bladder cancer program at Tulane University with a focus on clinical trials.  

 Dr. Barata has authored or co-authored more than 60 research publications in high-quality journals, such as Cancer, Annals of Oncology, and CA: Cancer journal Clinicians, with more than 700 scientific citations. He has presented multiple abstracts at important national and international meetings and has won multiple prestigious awards, including the Scholar-in-Training Award, AACR-NCI-EORTC Triple Meeting (2017) and the Annual Accelerating Anticancer Agent Development and Validation (AAADV) Program Scholarship (2018). He serves as a reviewer for prestigious peer-reviewed journals, such as JAMA Oncology, ASCO and Journal Global Oncology. 

Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP

Associate Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, UConn School of Medicine

Dr. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin–Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board-certified oncology pharmacist. Dr. Holle has worked as an oncology pharmacist for over 20 years in a variety of settings including private hospitals, academic medical centers, and medical communications. Currently, Dr. Holle is an Associate Clinical Professor at the UConn School of Pharmacy and Associate Professor at the UConn School of Medicine. Her practice site is at the UConn Health Carole and Ray Neag Comprehensive Cancer Center, where she works in a team-based ambulatory care clinic focusing on genitourinary and gastrointestinal cancers and in another team based-clinic focusing on hematologic malignancies.  

Dr. Holle is a Past President of HOPA and a past Secretariat member and Treasurer of the International Society of Oncology Pharmacy Practitioners (ISOPP). She is also an active member in many other professional oncology and pharmacy organizations. Dr. Holle’s clinical research program focuses on numeracy and patient decision-making, oncology quality improvement initiatives, medical marijuana, and oral anticancer therapy management.  

Webinar

Key:

Complete

Next

Failed

Available

Locked

How to Register

You must have a State Society or ACCC account to register for this event, which will enable you to register for future events and courses with just one click.

If You DO NOT Have an Account: 

• To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.”
• Click the green “Log In” button, then follow the proceeding steps, below. 

State Society and ACCC Members: 

• Click "Reset Password" and you will receive an email with a link to update your password. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
• If you do not receive an email or need assistance with resetting your password, please contact membership@accc-cancer.org.

Non-members:

•  Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
• Click “eLearning” at the top of your profile page to go back to the eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
• The green box in the upper right corner of this page will indicate “You are registered!” 

If You Have an Account: 

• Please click the “Log In” button on the right side of this screen. You will be taken to the main login page that displays your email and password. 
• Click the “Log in” button.
• You will be automatically redirected back to the event page, and the green box in the upper right corner will say that “You are registered!” 

PRO TIP: If you save your password to your computer and remain logged in, you can register for additional events and courses in a matter of seconds—with just one click! 

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the event. 

*If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact  April Gascon for registration information. 

Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this event. For assistance with registration or if you do not receive an email, please contact  registration@accc-cancer.org.